Open-market SellNotable 50/100
filed 2026-10-06KPOfficer
Kaiser Peter - Chief Development Officer - $70.4K
Insiders sell for many reasons (diversification, tax, personal); size and clustering matter more than a single sale.
View source filingO
SEC EDGAR - Form 4 insider activity
Ocular Therapeutix, Inc $OCUL
Tracked equity - 2 filings indexed by Nortis
Nortis signal thesis
Selling activity is leading recent insider flow. Review size, role and filing context.
0
OM buys - 90d
2
OM sells - 90d
0
Routine filings
0
Cluster filings
$76.6K
Largest trade
50/100
Avg signal score
Filing tape
Recent filings
Open-market SellNotable 50/100
filed 2026-10-06HSOfficer
Heier Jeffrey S. - Chief Scientific Officer - $76.6K
Insiders sell for many reasons (diversification, tax, personal); size and clustering matter more than a single sale.
View source filing